Funding Opportunity RFA-DA-23-004 from the NIH Guide for Grants and Contracts. This initiative will support exploitation of single cell technologies (transcriptome, epigenome, nucleome, and other emerging single cell assays) to identify the unique molecular features of cells involved in SUDs and/or HIV replication, latency, or reservoirs.

Interact with science teams and users to understand requirements and identify improvements to the software. Process, clean and verify the integrity of data used…
From Genus Plc - Tue, 15 Mar 2022 03:18:03 GMT - View all DeForest, WI jobs

Notice NOT-OD-22-087 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-086 from the NIH Guide for Grants and Contracts

Notice NOT-OD-22-085 from the NIH Guide for Grants and Contracts

Determines and performs appropriate bioinformatic analysis of data generated through high complexity techniques. Along with Flexible Spending options.
From Medical College of Wisconsin - Mon, 14 Mar 2022 15:09:49 GMT - View all Milwaukee, WI jobs

Adapts bioinformatics tools, visualization packages, and annotation resources for research projects to independently and accurately perform research analysis.
From Medical College of Wisconsin - Mon, 14 Mar 2022 15:09:29 GMT - View all Menomonee Falls, WI jobs

£33,272-£41,709 per annum: Wellcome Sanger Institute: We are looking to appoint a highly motivated postdoctoral fellow interested in systems immunology to join Menna Clatworthy’s group at the Wellcome ... Cambridgeshire

£33,272 to £44,971 per annum: Wellcome Sanger Institute: A new opportunity has arisen for a Postdoctoral Fellow in Genome Variation and we are looking for outstanding computational scientists to join our ... Cambridgeshire

£46,199 - £55,000 per annum: Wellcome Sanger Institute: We are recruiting a Principal Bioinformatician for Pathogen Informatics, a software development and bioinformatics support team in the Parasites an... Cambridgeshire (GB)

Funding Opportunity PAR-22-133 from the NIH Guide for Grants and Contracts. This Funding Opportunity Announcement (FOA) is to provide support for research Centers that (1) conduct drug abuse and addiction research in any area of NIDAs mission, (2) have outstanding innovative science, (3) are multidisciplinary, thematically integrated, synergistic, and (4) serve as national resource(s) to provide educational and outreach activities to drug abuse research communities, educational organizations, the general public, and policy makers in the NIDA research fields. It is expected that a Center will transform knowledge in the sciences it is studying. Incremental work should not be the focus of Center activities; rather, new and creative directions are required. The P50 Center of Excellence is expected to foster the career development and mentoring of new investigators who would be given meaningful roles to play in the Center projects. A goal of this program is to create NIDA Centers that are national community resources for furthering drug abuse research by sharing their findings, their data, and their resources as appropriate for researchers to use and build upon and to advance research in this field.

Funding Opportunity RFA-DA-23-009 from the NIH Guide for Grants and Contracts. oThis initiative will fund exploratory or pilot research projects to test interventions that address social connectedness and/or loneliness in order to prevent or treat SUDs or enhance recovery for individuals with SUDs. Interventions funded through this initiative should build on foundational, epidemiologic research on social connectedness and loneliness, and help contribute to a more unified theory about the role of loneliness and social connectedness in substance use and SUDs. Interventions could be delivered at the individual, dyadic, family or community level, and could include telehealth platforms. Community level interventions that focus on structural/environmental changes would be encouraged as a way of addressing social determinants of health. Such interventions could be implemented in a range of settings, including workplace, social media/online, educational, housing, and recovery centers, among others. Ultimately, the goal is to produce user-centered research that provides practical, cost-effective, scalable, and sustainable solutions to addressing substance use and addiction.

Funding Opportunity RFA-DA-23-010 from the NIH Guide for Grants and Contracts. This initiative will fund exploratory or pilot research projects to test interventions that address social connectedness and/or loneliness in order to prevent or treat SUDs or enhance recovery for individuals with SUDs. Interventions funded through this initiative should build on foundational, epidemiologic research on social connectedness and loneliness, and help contribute to a more unified theory about the role of loneliness and social connectedness in substance use and SUDs. Interventions could be delivered at the individual, dyadic, family or community level, and could include telehealth platforms. Community level interventions that focus on structural/environmental changes would be encouraged as a way of addressing social determinants of health. Such interventions could be implemented in a range of settings, including workplace, social media/online, educational, housing, and recovery centers, among others. Ultimately, the goal is to produce user-centered research that provides practical, cost-effective, scalable, and sustainable solutions to addressing substance use and addiction.

Funding Opportunity RFA-HL-23-007 from the NIH Guide for Grants and Contracts. The purpose of this program is to provide continued support to Transition Scholars who have successfully matriculated through the NIH Stimulating Access to Research in Residency (StARR) R38 program as resident investigators, and who demonstrate potential and continued interest in pursuing careers as clinician-investigators. Awards will provide 12-24 months of mentored research and career development support to those individuals who completed R38 research training, have secured a clinical fellowship or early-career faculty appointment (as instructor or assistant professor for less than 40 months at the time of submission or resubmission), and propose a strong research and career development plan towards continued, successful research careers.

Funding Opportunity RFA-LM-22-001 from the NIH Guide for Grants and Contracts. The purpose of this NLM R25 program is to support short-term educational activities that encourage undergraduates and masters students from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further training and careers in biomedical informatics and data science.

Build, document, and maintain computational pipelines for NGS data analysis for genomics and epi-genomics. Develop new computational tools and or apply existing…
From West Virginia University - Sun, 13 Mar 2022 10:08:36 GMT - View all Morgantown, WV jobs

Funding Opportunity RFA-MH-22-200 from the NIH Guide for Grants and Contracts. This initiative seeks to foster research targeting the reduction and elimination of mental health disparities by racial and ethnic groups, geographical settings, and socioeconomic status in the United States. It solicits research projects using the R01 mechanism to aggregate and examine existing data sets to increase understanding of mental health disparities and how to intervene to reduce mental health disparities and achieve mental health equity across the lifespan. This includes examining: 1) factors that contribute to, exacerbate and reduce disparities at multiple levels (e.g., policy, community, school, family, individual) at different developmental stages; 2) etiology and trajectories; and 3) prevention and treatment interventions and services and their implementation and dissemination. NIH-designated U.S. health disparity populations include Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations, and sexual and gender minorities (NOT-OD-15-089).

Notice NOT-AG-22-019 from the NIH Guide for Grants and Contracts

Funding Opportunity PAR-22-104 from the NIH Guide for Grants and Contracts. This funding opportunity announcement (FOA) is a reissue due to an omission of TRAINING RECORD review questions in Section V. This FOA encourages applications for the Chronic, Non-Communicable Diseases and Disorders Across the Lifespan: Fogarty International Research Training Award (NCD-LIFESPAN) D43 program for institutional research training programs in low-and middle-income countries (LMICs, as defined by the World Bank classification system). Applications may be for collaborations between institutions in the U.S and an eligible LMIC or may involve just LMIC institutions if there is a previous track record of externally funded research and/or research training programs by the lead LMIC institution. The proposed institutional research training program is expected to sustainably strengthen the NCD research capacity of the LMIC institutions, and to train in-country experts to develop and conduct research on NCDs across the lifespan, with the long-range goal of developing and implementing evidence-based interventions relevant to their countries. The main focus of research training covered in the application must be relevant to the interests of at least one of the participating NIH ICs as stated by each in this FOA. Other NCD topics may be included as secondary and complementary focus areas. This Funding Opportunity Announcement (FOA) allows support of trainees as the lead investigator of an independent clinical trial; or a separate ancillary study to an existing trial; or to gain research experience in a clinical trial led by another investigator, as part of their research and career development.

Funding Opportunity RFA-AI-22-019 from the NIH Guide for Grants and Contracts. The purpose of this Funding Opportunity Announcement (FOA) is to support pandemic preparedness by providing an opportunity for facility improvements and building systems upgrades at existing BSL3 and BSL4 biocontainment laboratories engaged in research on RNA viruses of pandemic potential to facilitate the conduct of biomedical research on vaccines and therapeutics.